Amneal Pharmaceuticals, Inc. Quarterly Goodwill in USD from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Amneal Pharmaceuticals, Inc. quarterly Goodwill history and growth rate from Q4 2016 to Q3 2024.
  • Amneal Pharmaceuticals, Inc. Goodwill for the quarter ending September 30, 2024 was $598M, a 0.05% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $598M -$307K -0.05% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $599M -$673K -0.11% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $599M -$607K -0.1% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $599M -$224K -0.04% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $599M -$873K -0.15% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $599M -$1.77M -0.29% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $599M -$3.74M -0.62% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $599M +$5.84M +0.98% Dec 31, 2022 10-Q 2024-11-12
Q3 2022 $600M +$33.1M +5.84% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $601M +$51.9M +9.45% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $603M +$80.1M +15.3% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $593M +$70.2M +13.4% Dec 31, 2021 10-K 2024-03-14
Q3 2021 $566M +$43.7M +8.36% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $549M +$21.6M +4.1% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $523M +$8.03M +1.56% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $523M +$103M +24.6% Dec 31, 2020 10-K 2023-03-03
Q3 2020 $523M +$103M +24.5% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $527M +$107M +25.6% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $515M +$93.1M +22.1% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $420M -$6.72M -1.58% Dec 31, 2019 10-K 2022-03-01
Q3 2019 $420M +$9.06M +2.21% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $420M +$33.5M +8.68% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $422M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $426M +$400M +1512% Dec 31, 2018 10-K 2021-03-01
Q3 2018 $411M Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $386M Jun 30, 2018 10-Q 2018-08-09
Q4 2017 $26.4M -$2M -7.02% Dec 31, 2017 10-K 2020-03-02
Q4 2016 $28.4M Dec 31, 2016 10-K 2019-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.